Bone defect filling with a novel rattan-wood based not-sintered hydroxyapatite and beta-tricalcium phosphate material (b.Bone™) after tricortical bone graft harvesting - A consecutive clinical case series of 9 patients.
Biomaterial
Bone defect
Hydroxyapatite
Iliac crest
beta-tricalcium phosphate
Journal
Trauma case reports
ISSN: 2352-6440
Titre abrégé: Trauma Case Rep
Pays: Netherlands
ID NLM: 101711730
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
accepted:
17
02
2023
entrez:
28
2
2023
pubmed:
1
3
2023
medline:
1
3
2023
Statut:
epublish
Résumé
Harvesting of tricortical bone graft from the iliac crest is an integral part of bone defect reconstruction in orthopaedic surgery. There are several options for filling the iliac crest defect area to avoid hematoma, pain, hernias and cosmetic issues, including different gelatin-based and other alternative biomaterials. Recently, a novel rattan-wood based not-sintered hydroxyapatite and beta-tricalcium phosphate material (b.Bone™, GreenBone ORTHO S.p.A Faenza, Italy) was shown to promote bone healing in an experimental setting. The goal of the current work is to report clinical and radiographical outcomes of a consecutive case series of 9 patients with defect filling at the iliac crest with this novel scaffold biomaterial after tricortical bone graft harvesting with a minimum follow-up of 6 months. All 9 patients (8 male, 1 female) with an average age of 42.7 years (range: 18-76 years) had tricortical bone graft harvesting from the iliac crest for different reconstructive procedures at the extremities and received blocks of the biomaterial with an average size of 26.3 × 16.8 × 10 mm (length, height, width; range: 15 × 15 × 10 to 40 × 20 × 10 mm). Intraoperative handling of the biomaterial was easy and the blocks could be customized to the individual size of the defect with standard surgical instruments and were press-fitted into the defect. All 9 patients showed uneventful wound healing at the iliac crest and 7 patients reported no pain (VAS: 0) and two patients only mild pain (VAS:1 and VAS:3) after an average follow-up of 9.8 months (range: 6-16 months). There was no post-operative hematoma, surgical revision or other implant-related complications at the iliac crest. In all patients, good radiographical integration without dislocation of the implant and good bony integration was observed. The use of this novel biomaterial for iliac crest defect filling was associated with good clinical and radiographical outcomes after an average follow-up of 9.8 months.
Identifiants
pubmed: 36851907
doi: 10.1016/j.tcr.2023.100805
pii: S2352-6440(23)00053-5
pmc: PMC9958041
doi:
Types de publication
Case Reports
Langues
eng
Pagination
100805Informations de copyright
© 2023 The Authors. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
VA, TB and MP are paid consultants for GREENBONE ORTHO S.p.A., 48018 Faenza (RA), Italy.
Références
Eur Spine J. 1999;8(6):491-4
pubmed: 10664309
J Orthop Trauma. 2010 Mar;24 Suppl 1:S36-40
pubmed: 20182233
J Mater Sci Mater Med. 2021 Jan 20;32(1):3
pubmed: 33471246
Injury. 2011 Sep;42 Suppl 2:S3-15
pubmed: 21704997
Front Bioeng Biotechnol. 2021 Sep 27;9:734486
pubmed: 34646817
Biomater Sci. 2018 Dec 18;7(1):307-321
pubmed: 30468436
BMJ Case Rep. 2022 Mar 9;15(3):
pubmed: 35264389
J Neurosurg Spine. 2012 Jun;16(6):565-72
pubmed: 22500584
J Biomed Mater Res B Appl Biomater. 2020 Apr;108(3):600-611
pubmed: 31095882
Bioengineering (Basel). 2021 Dec 21;9(1):
pubmed: 35049710
J Biomed Mater Res B Appl Biomater. 2022 Feb;110(2):350-357
pubmed: 34291874
BMC Musculoskelet Disord. 2018 Jul 19;19(1):237
pubmed: 30025526
Int Orthop. 2012 Aug;36(8):1701-7
pubmed: 22729663
J Am Acad Orthop Surg Glob Res Rev. 2018 Mar 23;2(3):e088
pubmed: 30211382
J Bone Joint Surg Am. 2011 Dec 7;93(23):2227-36
pubmed: 22159859
Biomaterials. 2015 Sep;62:128-37
pubmed: 26048479